VOLUME 70
2009
NUMBER 4

Commentary

446 Closing the Efficacy-Effectiveness Gap: Translating Both the What and the How From Randomized Controlled Trials to Clinical Practice

[PDF]

Original Articles

450 Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

[Abstract] [PDF]

458 McLean-Harvard International First-Episode Project: Two-Year Stability of DSM-IV Diagnoses in 500 First-Episode Psychotic Disorder Patients

[Abstract] [PDF]

467 Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia: A 1-Year, Open-Label Study

[Abstract] [PDF]

477 A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients

[Abstract] [PDF]

487 A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

[Abstract] [PDF]

500 Late-Onset Depression in Elderly Subjects From the Vienna Transdanube Aging (VITA) Study

[Abstract] [PDF]

509 Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A Multicenter, Prospective, and Naturalistic Study

[Abstract] [PDF]

518 A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

[Abstract] [PDF]

526 Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

[Abstract] [PDF]

540 Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

[Abstract] [PDF]

550 A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

[Abstract] [PDF]

562 Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial

[Abstract] [PDF]

572 A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

[Abstract] [PDF]

Focus on Alzheimer's Disease and Related Disorders

582 Commentary. Grumpy Old Men (and Women): Mere Hassle or Meaningful Clinical Evidence?

[PDF]

584 Mild Behavioral Impairment and Risk of Dementia: A Prospective Cohort Study of 358 Patients

[Abstract] [PDF]

Academic Highlights

593 A Roadmap to Key Pharmacologic Principles in Using Antipsychotics: Application in Clinical Practice [CME]

[PDF]

Letters To the Editor

601 Venlafaxine-Induced Complex Visual Hallucinations in a 17-Year-Old Boy

[PDF]

603 Reliability, Not Overdiagnosis

[PDF]

• Reply by Mark Zimmerman, Camilo J. Ruggero, Iwona Chelminski, and Diane Young

[PDF]

604 Use of Risperidone Long-Acting Injection to Support Treatment Adherence and Mood Stabilization in Pediatric Bipolar Patients: A Case Series

[PDF]

Book Reviews

607 The Physician as Patient: A Clinical Handbook for Mental Health Professionals

[PDF]

607 Stahl’s Essential Psychopharmacology Online,revised and updated 3rd ed

[PDF]

608 Patients With Substance Abuse Problems: Effective Identification, Diagnosis, and Treatment

[PDF]

608 Clinical Handbook of Obsessive-Compulsive Disorder and Related Problems

[PDF]

Electronic CME Activities

Available through www.psychiatrist.com/toc

e07 Remission as the "Gold Standard" of Treatment for Depression With and Without Physical Symptoms

[Abstract]

e08 Efficacy of Agents in Treating Mania

[Abstract]

e09 Diagnostic Assessment of Major Depressive Disorder

[Abstract]

e10 Pain and the Brain: Chronic Widespread Pain

[Abstract]